D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Microbiology D-index 55 Citations 7,855 100 World Ranking 1642 National Ranking 683

Overview

What is he best known for?

The fields of study he is best known for:

  • Virus
  • Antibody
  • Immune system

His primary areas of study are Virology, Virus, Flavivirus, Immunogenicity and Dengue virus. His Virology research is multidisciplinary, incorporating perspectives in Cytoplasm and Antibody, Immunology. His research in Virus intersects with topics in Immunoelectron microscopy, Endocytosis and Monocyte.

His research investigates the connection between Immunogenicity and topics such as Adjuvant that intersect with issues in Clinical trial, Adverse effect and Randomized controlled trial. His work on Antibody-dependent enhancement is typically connected to Recombinant virus as part of general Dengue virus study, connecting several disciplines of science. His Vaccination research incorporates themes from Viremia, Dengue vaccine and Reactogenicity.

His most cited work include:

  • Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys (374 citations)
  • Vaccine protection against Zika virus from Brazil (369 citations)
  • Rapid development of a DNA vaccine for Zika virus (276 citations)

What are the main themes of his work throughout his whole career to date?

Virology, Virus, Dengue fever, Dengue virus and Vaccination are his primary areas of study. His Virology study integrates concerns from other disciplines, such as Antibody, Immunology and Immunogenicity. His Virus research incorporates elements of Clone and Microbiology.

Kenneth H. Eckels has included themes like Microneutralization Assay, Viremia, Yellow fever and Serial passage in his Dengue fever study. His Dengue virus research includes elements of Attenuated vaccine, Virulence, Serotype and Vaccine efficacy. His study on Vaccination also encompasses disciplines like

  • Dengue vaccine which intersects with area such as Reactogenicity,
  • Zika virus which connect with DNA vaccination.

He most often published in these fields:

  • Virology (85.71%)
  • Virus (56.04%)
  • Dengue fever (53.85%)

What were the highlights of his more recent work (between 2014-2021)?

  • Virology (85.71%)
  • Vaccination (36.26%)
  • Dengue virus (48.35%)

In recent papers he was focusing on the following fields of study:

His primary scientific interests are in Virology, Vaccination, Dengue virus, Immunogenicity and Dengue fever. His Virology study combines topics in areas such as Immunology and Immunity. His biological study focuses on Dengue vaccine.

His studies examine the connections between Immunogenicity and genetics, as well as such issues in Clinical trial, with regards to Randomized controlled trial. His Dengue fever research focuses on Microneutralization Assay and how it connects with Retrospective cohort study and Incidence. The Zika virus study combines topics in areas such as Viremia, Flavivirus and Immunization, DNA vaccination.

Between 2014 and 2021, his most popular works were:

  • Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys (374 citations)
  • Vaccine protection against Zika virus from Brazil (369 citations)
  • Rapid development of a DNA vaccine for Zika virus (276 citations)

In his most recent research, the most cited papers focused on:

  • Virus
  • Antibody
  • Immune system

Kenneth H. Eckels focuses on Zika virus, Virology, Vaccination, Immunology and DNA vaccination. In his study, Clinical trial, Adverse effect, Randomized controlled trial and Internal medicine is strongly linked to Immunogenicity, which falls under the umbrella field of Zika virus. His biological study deals with issues like Neutralizing antibody, which deal with fields such as Dengue vaccine, Vaccination schedule, Dengue fever and Dengue virus.

His Immunology study focuses mostly on Antibody, Viral Vaccine and Flavivirus. He interconnects Viremia, Congenital disease and Outbreak in the investigation of issues within DNA vaccination. His Immunization study combines topics from a wide range of disciplines, such as Titer, Antibody titer, Virus and Immunity.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Vaccine protection against Zika virus from Brazil

Rafael A. Larocca;Peter Abbink;Jean Pierre S. Peron;Paolo M. de A. Zanotto.
Nature (2016)

429 Citations

Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys

Peter Abbink;Rafael A. Larocca;Rafael A. De La Barrera;Christine A. Bricault.
Science (2016)

394 Citations

Rapid development of a DNA vaccine for Zika virus

Kimberly A. Dowd;Sung-Youl Ko;Kaitlyn M. Morabito;Eun Sung Yang.
Science (2016)

282 Citations

Phase I trial of 16 formulations of a tetravalent live-attenuated dengue vaccine.

Robert Edelman;Steven S. Wasserman;Sacared A. Bodison;Robert J. Putnak.
American Journal of Tropical Medicine and Hygiene (2003)

232 Citations

Monoclonal Antibodies Against Dengue 2 Virus E-Glycoprotein Protect Mice Against Lethal Dengue Infection,

B. M. Kaufman;P. L. Summers;D. R. Dubois;K. H. Eckels.
American Journal of Tropical Medicine and Hygiene (1987)

211 Citations

An evaluation of dengue type-2 inactivated, recombinant subunit, and live-attenuated vaccine candidates in the rhesus macaque model.

J. Robert Putnak;Beth-Ann Coller;Gerald Voss;David W. Vaughn.
Vaccine (2005)

191 Citations

Monoclonal antibodies for dengue virus prM glycoprotein protect mice against lethal dengue infection

B M Kaufman;P L Summers;D R Dubois;W H Cohen.
American Journal of Tropical Medicine and Hygiene (1989)

182 Citations

Vaccination of human volunteers with monovalent and tetravalent live-attenuated dengue vaccine candidates.

Wellington Sun;Robert Edelman;Niranjan Kanesa-Thasan;Kenneth H. Eckels.
American Journal of Tropical Medicine and Hygiene (2003)

182 Citations

Development of a Purified, Inactivated, Dengue-2 Virus Vaccine Prototype in Vero Cells: Immunogenicity and Protection in Mice and Rhesus Monkeys

Robert Putnak;David A. Barvir;Jeanne M. Burrous;Doria R. Dubois.
The Journal of Infectious Diseases (1996)

167 Citations

Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials.

Kayvon Modjarrad;Leyi Lin;Sarah L George;Sarah L George;Kathryn E Stephenson;Kathryn E Stephenson.
The Lancet (2017)

167 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Kenneth H. Eckels

Michael S. Diamond

Michael S. Diamond

Washington University in St. Louis

Publications: 47

Stephen S. Whitehead

Stephen S. Whitehead

National Institutes of Health

Publications: 42

María G. Guzmán

María G. Guzmán

Instituto de Medicina Tropical “Pedro Kourí”

Publications: 41

Francis A. Ennis

Francis A. Ennis

University of Massachusetts Medical School

Publications: 40

Alan D.T. Barrett

Alan D.T. Barrett

The University of Texas Medical Branch at Galveston

Publications: 39

Dan H. Barouch

Dan H. Barouch

Beth Israel Deaconess Medical Center

Publications: 35

Pei-Yong Shi

Pei-Yong Shi

The University of Texas Medical Branch at Galveston

Publications: 34

Theodore C. Pierson

Theodore C. Pierson

National Institutes of Health

Publications: 34

Anna P. Durbin

Anna P. Durbin

Johns Hopkins University

Publications: 32

Ichiro Kurane

Ichiro Kurane

National Institutes of Health

Publications: 31

Scott C. Weaver

Scott C. Weaver

The University of Texas Medical Branch at Galveston

Publications: 31

Peter W. Mason

Peter W. Mason

Novartis (Switzerland)

Publications: 28

Bruce L. Innis

Bruce L. Innis

GlaxoSmithKline (United Kingdom)

Publications: 28

Alan L. Rothman

Alan L. Rothman

University of Rhode Island

Publications: 27

Brian R. Murphy

Brian R. Murphy

National Institutes of Health

Publications: 25

Eva Harris

Eva Harris

University of California, Berkeley

Publications: 24

Trending Scientists

Natalia Andrienko

Natalia Andrienko

Fraunhofer Institute for Intelligent Analysis and Information Systems

Guandong Xu

Guandong Xu

University of Technology Sydney

Nicos Makris

Nicos Makris

Southern Methodist University

Robert J. Le Roy

Robert J. Le Roy

University of Waterloo

C. David Sherrill

C. David Sherrill

Georgia Institute of Technology

Tony D. Williams

Tony D. Williams

Simon Fraser University

Christopher N. Johnson

Christopher N. Johnson

University of Tasmania

Scott K. Robinson

Scott K. Robinson

Florida Museum of Natural History

Marc Slattery

Marc Slattery

University of Mississippi

Kenneth W. Bayles

Kenneth W. Bayles

University of Nebraska Medical Center

Ronald L. Wilder

Ronald L. Wilder

National Institutes of Health

Carol E. Franz

Carol E. Franz

University of California, San Diego

Aileen M. Davis

Aileen M. Davis

University of Toronto

Nir Peled

Nir Peled

Ben-Gurion University of the Negev

Friedrich W. Hesse

Friedrich W. Hesse

Leibniz Institute for Neurobiology

Something went wrong. Please try again later.